[CytoReason in No Camels] cytoreason teams up with merck kgaa on cancer drug development

Source Node: 1239721

Israeli biotech startup CytoReason announced Wednesday that it is collaborating with German multinational science and technology company, Merck KGaA, Darmstadt, Germany, to profile one of its leading immuno-oncology drugs.

Read more here.

Source: https://blog.ourcrowd.com/cytoreason-teams-up-with-merck-kgaa-on-cancer-drug-development/

Time Stamp:

More from OurCrowd Blog